Dr. Linda Katz, the director of the FDA's Office of Cosmetics and Colors, said in a statement that the agency has “carefully considered the scientific evidence and complex policy issues related ...
director of the FDA Office of Generic Drugs, said in a statement. “Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high-quality ...
Some results have been hidden because they may be inaccessible to you